Skip to content

The feasibility and acceptability of an online mindfulness-based stress reduction program for chronic musculoskeletal pain: protocol for a pilot randomised controlled trial.

Anita B Amorim, Trudy Rebbeck, Nicholas T Van Dam, Charlotte Johnstone, Claire Ashton-James, Nathalia Costa, Talia Barnet-Hepples, Matthew Jennings, Kathryn Refshauge, Evangelos Pappas

Pilot and feasibility studies March 15, 2025 DOI: 10.1186/s40814-025-01612-w via PubMed

Summary

AI-generated from the abstract

A pilot randomized controlled trial will test the feasibility and acceptability of an online mindfulness-based stress reduction (MBSR) program for people with chronic musculoskeletal pain who are on waitlists for multidisciplinary pain clinics in Australia's public healthcare system. Thirty-two participants from two clinics in Sydney will be randomly assigned to either the online MBSR group or usual care. The study will assess feasibility, patient-reported outcomes, adherence to mindfulness practice, and adverse events using validated questionnaires, along with qualitative interviews to explore participants' experiences. Results will guide the design of larger future trials.

Study at a glance

Characteristics Mixed-methods pilot randomised controlled trial with an embedded qualitative study Randomized Pilot study Peer reviewed
Sample size 32
Population Individuals with chronic musculoskeletal pain on waitlists at two multidisciplinary pain management centres within the Sydney Local Health District, New South Wales, Australia
Intervention Mindfulness-based stress reduction (MBSR)
Keywords Chronic musculoskeletal pain Clinical trial Feasibility Mindfulness-based stress reduction Pilot study
Key finding The study aims to assess the feasibility, acceptability, and potential efficacy of an online MBSR program for patients waitlisted for multidisciplinary pain care.

Abstract

Chronic musculoskeletal pain conditions affect millions of people worldwide and place a significant burden on individuals and the healthcare systems. Managing chronic musculoskeletal pain requires a multidisciplinary approach that considers biological, psychological, and social factors. However, access to multidisciplinary pain care is challenging, and long wait times can lead to increased stress and health deterioration. Mindfulness-based stress reduction (MBSR) is a mind-body approach developed specifically to reduce the distress of living with chronic conditions, such as chronic musculoskeletal pain. This study proposed a novel approach by offering an online MBSR program to patients on waitlists to attend a multidisciplinary pain clinic in Australia's public healthcare system that could improve health outcomes. The study aims to assess the feasibility, acceptability, and potential efficacy of this approach using a pilot study design with a mixed-methods approach. This is a mixed-methods pilot randomised controlled trial with an embedded qualitative study. Participants will be recruited from waitlists at two multidisciplinary pain management centres within the Sydney Local Health District in New South Wales, Australia. This pilot trial will randomly assign 32 individuals with chronic musculoskeletal pain to either an online MBSR group or a usual care control group. Feasibility outcomes, patient-reported outcomes, adherence to mindfulness practice, and adverse events will be assessed using validated questionnaires. Semi-structured interviews will be conducted with participants in the MBSR group to explore their experiences and evaluate acceptability, and barriers and facilitators of engagement with the intervention. This pilot study will evaluate a novel approach to integrating MBSR into the Australian public healthcare system as a mechanism for providing support to individuals with chronic musculoskeletal pain who are waitlisted for a multidisciplinary pain management program. Findings from this study will indicate the feasibility, acceptability, safety, and preliminary efficacy of this approach in terms of patient-reported outcomes to guide the design of future large-scale clinical trials. This trial was prospectively registered in the Australian New Zealand Clinical Trials Registry (ACTRN12622000822785).

Comments

No comments yet.

Log in to comment